Innovative Eyewear Inc (LUCY) stock

LUCYNasdaqOphthalmic GoodsFiscal year ends December 31Also trades as LUCYW

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 9, 2026Score 12/3048% below fair value

$0.81+0.00 (+0.21%)

Close on Nov 13, 2026Market cap $6.96MP/E –Yield –

Innovative Eyewear statistics

69 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Jan 6, 2027 (estimated, after the close)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $6.96M; $498.53M
Enterprise Value: $3.76M; $433.11M
PS Ratio: 2.61; 2.94
PB Ratio: 0.94; 3.24
P/TBV Ratio: 1.03; 4.81

Enterprise valuationIndustry

EV / Sales: 1.41; 2.60

Share statisticsIndustry

Shares Outstanding: 9M; 43M
Shares Change (YoY): 166.8%; 3.32%
Float: 8M; 37M
Shares Held by Insiders: 11.5%; 10.5%
Shares Held by Institutions: 10.4%; 60.5%

Short sellingIndustry

Short Interest: 132,820; –
Short Interest Change: -8.95%; -2.57%
Days to Cover: 1.08; 3.94

Stock price statisticsIndustry

52-Week High: $2.00; –
52-Week Low: $0.65; –
20-Day Moving Average: $0.83; –
50-Day Moving Average: $0.87; –
200-Day Moving Average: $0.94; –
Average True Range (14): $0.05; –
Price Change (1 Week): -2.02%; 0.99%
Price Change (1 Month): -4.06%; -3.52%
Price Change (3 Months): 15.4%; -7.86%
Price Change (6 Months): -13.1%; -1.12%
Price Change (YTD): -18.9%; -2.92%
Price Change (1 Year): -54.3%; -1.37%
Price Change (3 Years): -90.6%; 3.24%
Average Volume (10 Days): 135,534; –
Average Volume (20 Days): 132,446; –
Average Volume (90 Days): 3M; –
Relative Volume: 0.06; 0.76
Relative Strength Index (14): 43.1; 46.7
Volatility (1 Year): 125.7%; 64.2%
Beta (5 Years): 1.93; 1.04

MarginsIndustry

Gross Margin: 21.3%; 55.9%
Profit Margin: -285.2%; -9.29%
FCF Margin: -276.1%; 0.65%

Returns on capitalIndustry

Return on Equity (ROE): -103.0%; -17.3%
Return on Assets (ROA): -92.5%; -12.3%

Financial positionIndustry

Current Ratio: 9.12; 2.49
Quick Ratio: 4.15; 1.53

GrowthIndustry

Revenue Growth (YoY): 62.6%; 9.42%
Revenue Growth (3Y CAGR): 59.2%; 7.08%

EfficiencyIndustry

Asset Turnover: 0.32; 0.59
Inventory Turnover: 1.24; 2.20
Revenue Per Employee: $204.74K; $331.99K
Profits Per Employee: -$583.94K; -$46.47K
Employee Count: 13; 193
WACC: 14.8%; 9.91%

Income statement (TTM)Industry

Revenue: $2.66M; $108.17M
Gross Profit: $567.45K; $62.29M
Net Income: -$7.59M; -$6.19M
EPS (Diluted): -$1.90; -$0.11

Balance sheetIndustry

Cash & Short-Term Investments: $3.20M; $38.97M
Net Cash (Debt): $3.20M; $3.95M
Net Cash Per Share: $0.37; $0.26
Equity (Book Value): $7.37M; $63.80M
Book Value Per Share: $0.86; $3.26
Tangible Book Value: $6.78M; $11.61M
Working Capital: $6.73M; $57.32M

Cash flow (TTM)Industry

Operating Cash Flow: -$7.28M; -$483.87K
Capital Expenditures: -$72.51K; -$3.94M
Free Cash Flow: -$7.35M; -$238.00K
FCF Per Share: -$0.85; -$0.00

Dividends and yieldsIndustry

Earnings Yield: -109.1%; -4.76%
FCF Yield: -105.6%; 0.28%

Scores and fair valueIndustry

Altman Z-Score: -0.28; 2.47
Piotroski F-Score: 5; 5
Beneish M-Score: -2.41; -2.64

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	LUCY	S&P 500	Difference	LUCY per year	S&P 500 per year
1 month	-5.2%	-3.0%	−2.1 pts
3 months	+7.2%	-2.8%	+9.9 pts
Year to date	-18.9%	+11.5%	−30.4 pts
1 year	-47.9%	+13.5%	−61.3 pts
3 years	-90.3%	+77.7%	−168.0 pts	-54.0%	+21.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M LUCY shares were sold short on Oct 30, 2026, down 8.9% from the previous report. At recent volumes it would take 1.1 days to buy them back. Over the last 20 sessions, 44.8% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	132,820	-8.9%	122,757	1.1
Oct 15, 2026	145,869	-19.0%	155,785	1.0
Sep 30, 2026	180,001	+13.9%	189,566	1.0
Sep 15, 2026	158,090	-73.0%	233,061	1.0
Aug 31, 2026	584,824	+108.5%	19,229,689	1.0
Aug 14, 2026	280,516	-19.6%	187,477	1.5
Jul 31, 2026	348,901	-46.3%	267,518	1.3
Jul 15, 2026	650,128	+2511.3%	26,317,729	1.0
Jun 30, 2026	24,897	+33.5%	65,180	1.0
Jun 15, 2026	18,649	-44.2%	55,714	1.0
May 29, 2026	33,413	-39.4%	78,748	1.0
May 15, 2026	55,176	+105.2%	103,051	1.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

Where these numbers come from

Parsed from the XBRL in Innovative Eyewear's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-17 reverse split on Aug 12, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is LUCY.

Compare: LUCY vs VUZI · LUCY vs MSAI · LUCY vs FCUV · LUCY vs VYCO · LUCY vs SYNX

Revenue growth62.6% · median 7.2%

Gross margin21.3% · median 57.0%

Net margin-285.2% · median -238.2%

Company	Revenue	Growth
MSAI	$6.20M	+11.5%
VUZI	$5.46M	+2.9%
LUCY	$2.66M	+62.6%
VYCO	$1.71M	-10.2%
FCUV	$1.53M	+293.9%
SYNX	–	–

Company

Next earnings (est.): Jan 6, 2027, after close
Exchange: Nasdaq
Industry: Ophthalmic Goods
Fiscal year ends: December 31
Employees: 13
Auditor: Cherry Bekaert LLP
SEC CIK: 1808377

Advertisement
300 × 250

See a number that looks wrong?